Your shopping cart is currently empty

EGFR-IN-182 (Compound 4) is an EGFR inhibitor with an IC50 value of 199 nM. It additionally inhibits HSP90 and PI3K, with IC50 values of 5.007 μM and 13.596 μM, respectively. EGFR-IN-182 demonstrates potent antiproliferative activity against MCF-7 and MDA-MB-231 cells. It downregulates Cyclin D1, induces cell cycle arrest, enhances caspase-9 activity, and triggers apoptosis. EGFR-IN-182 also decreases the expression of ERK and AKT and is applicable for breast cancer research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | EGFR-IN-182 (Compound 4) is an EGFR inhibitor with an IC50 value of 199 nM. It additionally inhibits HSP90 and PI3K, with IC50 values of 5.007 μM and 13.596 μM, respectively. EGFR-IN-182 demonstrates potent antiproliferative activity against MCF-7 and MDA-MB-231 cells. It downregulates Cyclin D1, induces cell cycle arrest, enhances caspase-9 activity, and triggers apoptosis. EGFR-IN-182 also decreases the expression of ERK and AKT and is applicable for breast cancer research. |
| Targets&IC50 | EGFR:199 nM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.